NCT06949124 2025-09-10
A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
Jiangsu HengRui Medicine Co., Ltd.
Jiangsu HengRui Medicine Co., Ltd.
Jiangsu HengRui Medicine Co., Ltd.
Bayer
Millennium Pharmaceuticals, Inc.
National Center for Complementary and Integrative Health (NCCIH)